Results 191 to 200 of about 1,588,999 (218)

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Smoking, Dysbiosis and Weight Gain

Nature Reviews Microbiology, 2022
Ursula Hofer
exaly  

Multidisciplinary Standards of Care and Recent Progress in Pancreatic Ductal Adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Diane M Simeone   +2 more
exaly  

Home - About - Disclaimer - Privacy